newsfilter
← Latest News
GlobeNewswire·

Aravive to Participate In-Person at 34th Annual ROTH Conference

HOUSTON, March 07, 2022 (GLOBE NEWSWIRE) -- Aravive, Inc. (NASDAQ:ARAV), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, announced that Gail McIntyre, Ph.D., DABT, Chief Executive Officer of Aravive,